Ingredion Incorporated (FRA:CNP)
Germany · Delayed Price · Currency is EUR | Market Cap | 5.68B -19.6% |
| Revenue (ttm) | 6.32B -1.4% |
| Net Income | 518.18M -12.4% |
| EPS | 8.06 -10.0% |
| Shares Out | n/a |
| PE Ratio | 10.95 |
| Forward PE | 9.41 |
| Dividend | 2.83 (3.17%) |
| Ex-Dividend Date | Jul 1, 2026 |
| Volume | n/a |
| Open | 89.15 |
| Previous Close | 90.25 |
| Day's Range | 89.15 - 89.15 |
| 52-Week Range | 81.60 - 110.60 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 4, 2026 |
About Ingredion
Ingredion Incorporated, together with its subsidiaries, engages in the manufacture and sale of sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries worldwide. The company operates in Texture & Healthful Solutions; Food & Industrial Ingredients–LATAM; and Food & Industrial Ingredients–U.S./CANADA segments. It offers starch products for use in a range of processed foods; cornstarch; specialty paper starches for enhanced draina... [Read more]
Financial Performance
In 2025, Ingredion's revenue was $7.22 billion, a decrease of -2.84% compared to the previous year's $7.43 billion. Earnings were $729.00 million, an increase of 12.67%.
Financial numbers in USD Financial StatementsNews
Ingredion appoints Diego Reynoso as chief financial officer
Ingredion (INGR) announced the appointment of Diego Reynoso as chief financial officer effective October 1. He will serve as a member of the executive leadership team and report to Jim…
Diego Reynoso to join Ingredion as Chief Financial Officer
WESTCHESTER, Ill., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage industry, today announced the appoi...
Ingredion price target raised to $108 from $104 at UBS
UBS raised the firm’s price target on Ingredion (INGR) to $108 from $104 and keeps a Neutral rating on the shares.
Ingredion price target lowered to $118 from $120 at Barclays
Barclays lowered the firm’s price target on Ingredion (INGR) to $118 from $120 and keeps an Equal Weight rating on the shares.
Ingredion Earnings Call Transcript: Q2 2026
Q2 2026 saw 1% net sales growth and a 5% decline in adjusted operating income, with strong performance in Texture & Healthful Solutions offsetting operational and macroeconomic headwinds. The pending Tate & Lyle acquisition is on track, and guidance for 2026 remains largely unchanged.
Ingredion Earnings release: Q2 2026
Ingredion released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
Ingredion Slides: Q2 2026
Ingredion has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 4, 2026.
Ingredion Quarterly report: Q2 2026
Ingredion has published its Q2 2026 quarterly earnings report on August 4, 2026.
Ingredion backs FY26 adjusted EPS view $10.30-$10.90, consensus $10.79
The company still expects full-year 2026 net sales to be flat to up low single digits, reflecting volume growth and favorable foreign exchange, partially offset by lower price mix as…
Ingredion reports Q2 adjusted EPS $2.82, consensus $2.72
Reports Q2 revenue $1.85B, consensus $1.83B. “Ingredion (INGR) delivered a solid second quarter, with Texture & Healthful Solutions continuing its quarterly net sales volume growth and Food & Industri...
Ingredion backs FY26 adjusted EPS view $10.30-$10.90, consensus $10.79
Backs FY26 revenue view flat to up low single digits. “Looking ahead, we are focused on continued operational execution across our Food & Industrial Ingredients businesses and accelerating the growth…
Ingredion sees Q3 revenue up low single-digits
The company said, “For the third quarter of 2026, compared to the same quarter last year, the Company expects net sales to be up low single-digits. Reported and adjusted operating…
Ingredion reports Q2 adjusted EPS $2.82, consensus $2.72
Reports Q2 revenue $1.85B, consensus $1.83B. “Ingredion (INGR) delivered a solid second quarter, with Texture & Healthful Solutions continuing its quarterly net sales volume growth and Food & Industri...
Ingredion Incorporated Reports Second Quarter 2026 Results
Second quarter 2026 reported and adjusted* operating income decreased 31% and 5% compared to the second quarter 2025 Second quarter 2026 reported and adjusted EPS were $1.78 and $2.82, compared with $...
Ingredion notes Tate & Lyle shareholders accept 595 pence per share buyout
Ingredion (INGR) confirmed that shareholders of Tate & Lyle have accepted the terms of a recommended all-cash offer by Ingredion for the entire issued and to be issued share capital…
Ingredion's 595 pence All-Cash Offer to Acquire Tate & Lyle Accepted by Their Shareholders
Tate & Lyle shareholders accept Ingredion's recommended cash offer Shareholder acceptance marks an important milestone toward creating a global ingredient solutions leader with enhanced innovation and...
Ingredion to Release 2026 Second Quarter Financial Results On August 4, 2026
WESTCHESTER, Ill., July 14, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food manufacturing industry, will release its second ...
Ingredion completes sale of majority equity stake in Pakistan business
Ingredion (INGR) has completed the sale of a 51% interest in Rafhan Maize, a local manufacturer of food and industrial ingredients to a group of affiliated purchasers lead by Nishat…
Ingredion Completes Sale of Majority Equity Stake in Pakistan Business
Ingredion completes $165M sale of 51% Rafhan Maize stake in Pakistan, retaining 20% ownership to support growth in the Middle East and South Asia markets.
Ingredion Names Kenneth Escoe to Board of Directors
WESTCHESTER, Ill., June 11, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions for food, beverage and industrial applications, today announ...
Ingredion downgraded to Perform at Oppenheimer after Tate & Lyle bid
As previously reported, Oppenheimer downgraded Ingredion (INGR) to Perform from Outperform and removed the firm’s prior price target following the company’s proposed Tate & Lyle acquisition. While the...
Ingredion downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Kristen Owen downgraded Ingredion (INGR) to Perform from Outperform.
Ingredion Transcript: M&A announcement
A $5 billion all-cash acquisition will combine complementary ingredient portfolios, creating a global leader in specialty solutions with $10 billion in revenue and $1.8 billion EBITDA. The deal targets $130 million in annual cost synergies by 2030 and over 15% EPS accretion in year one.
Ingredion Press release: M&A announcement
Ingredion issued a press release on June 8, 2026, disclosing material business information to investors.
Ingredion Slides: M&A announcement
Ingredion has posted slides in relation to its latest quarterly earnings report, which was published on June 8, 2026.